Published on:
Authors: D. Mark Wilson
Topics:
A California ballot measure, which will be voted on in November, would require the state to pay no more for drugs than the Department of Veteran Affairs, one of the few federal agencies allowed to negotiate drug prices. Proponents of the ballot initiative say anywhere from three to seven million California residents enrolled in state-supported health programs could get access to lower-cost drugs. Opponents contend it would undermine the competitive market and not improve patient access to prescription drugs. Other payers could also see higher prices as costs are shifted onto the commercial market. Separately, a new report from the Campaign for Sustainable Rx Pricing unveiled a set of policy proposals this week aimed at increasing transparency, competition and value in the drug industry. Specifically, the report calls for requiring drug companies to disclose certain pricing information as a part of the drug approval process, and recommends HHS provide an annual report analyzing drug price increases for brands and generic drugs.
MORE NEWS STORIES
House Considers 15 Telehealth Bills Aimed at Increasing Access
April 12, 2024 | News
Maximizing Employer Influence for Next-Level Employee Benefits
March 22, 2024 | News
White House Spotlight on Pharmacy Benefit Managers
March 08, 2024 | News